Suppr超能文献

聚黏菌素 B 固定纤维的抗内毒素特性。

Anti-endotoxin Properties of Polymyxin B-immobilized Fibers.

机构信息

Biomedical Innovation Center, Shiga University of Medical Science, Otsu, Shiga, Japan.

Department of Surgery, Shiga University of Medical Science, Otsu, Shiga, Japan.

出版信息

Adv Exp Med Biol. 2019;1145:321-341. doi: 10.1007/978-3-030-16373-0_19.

Abstract

Polymyxin B is an antibiotic that shows strong bactericidal activity against Gram-negative bacteria, by binding to and inactivating endotoxin. Systemic administration of polymyxin B in humans is restricted because of its nephrotoxicity and neurotoxicity, and this compound was therefore considered a strong candidate ligand for the extracorporeal selective adsorption of circulating endotoxin in the blood. Toraymyxin® is a direct hemoperfusion column that uses polymyxin B attached to an insoluble carrier to bind endotoxin in the blood. In 1994, the Japanese National Health Insurance system approved the use of Toraymyxin for the treatment of endotoxemia and septic shock.In this chapter, we will review the development, clinical use, and efficacy of Toraymyxin, examine the structure of the Toraymyxin column, and comment on the current position of Toraymyxin in the treatment of severe sepsis and septic shock. We will also highlight some potential new applications of Toraymyxin for pulmonary diseases.

摘要

多粘菌素 B 是一种抗生素,通过与内毒素结合并使其失活,对革兰氏阴性菌表现出很强的杀菌活性。由于其肾毒性和神经毒性,多粘菌素 B 在人体中的全身给药受到限制,因此该化合物被认为是血液中循环内毒素体外选择性吸附的强候选配体。Toraymyxin®是一种直接血液灌流柱,它使用附着在不溶性载体上的多粘菌素 B 来结合血液中的内毒素。1994 年,日本国家健康保险系统批准使用 Toraymyxin 治疗内毒素血症和感染性休克。在本章中,我们将回顾 Toraymyxin 的发展、临床应用和疗效,检查 Toraymyxin 柱的结构,并对内毒素血症和感染性休克的治疗中 Toraymyxin 的现状进行评论。我们还将强调 Toraymyxin 在肺部疾病方面的一些潜在新应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c5/7123644/7843b58c0680/320407_1_En_19_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验